Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Tezepelumab for Severe Asthma
Recruiting2 awardsPhase 3
Saint Louis, Missouri
This trial is testing an injectable medication called Tezepelumab to help adults with severe asthma reduce their use of oral steroids. The medication works by reducing inflammation in the airways, which can make breathing easier. Tezepelumab has shown effectiveness in improving lung function in patients with severe, uncontrolled asthma.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service